Kennedy wants to create "wellness drug rehabilitation farms." But the U.S. tried it before, and it didn't work.

Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic <a target=_blank href= ...

We recently compiled a list of the 7 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...

QIAGEN N.V.’s QGEN long-term business strategy focuses on forming partnerships for the development, commercialization, marketing and distribution of existing and future products. The company sees ...

Patients with squamous cell carcinoma of the head and neck were randomly assigned to receive either intensity-modulated radiotherapy with weekly cetuximab or radiotherapy alone.

With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

President Donald Trump’s Medicare agency is seeking to bring more transparency to the US government’s drug price negotiation ...

Plus: How AI propelled Nvidia up the list and other insights from this year's survey of corporate reputations.

First Solar will report financial results for the fourth quarter and full year ended Dec. 31, 2024, after the closing bell on ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...